51����

Focusing on a new treatment paradigm, this webinar will touch on the history of and recent progress in the development of psychedelic-assisted psychotherapy for mental health disorders, including current options in ketamine-assisted psychotherapy. Dr. Michael Verbora, MBA MD (51���� Medical Director, Toronto) and Dr. Ben Medrano, MD (51���� Medical Director, New York) will discuss the current evidence and ongoing clinical work that 51���� Health is facilitating, using psychedelic medicine to treat treatment-resistant mental health conditions with lasting success.

Dr. Verbora is 51����'s Medical Director in Toronto. He earned an M.D. from Schulich School of 51���� at Western University in 2013 before completing his residency at the University of Toronto. He has emerged as a thought leader and is passionate about furthering his knowledge on holistic healing.

Dr. Ben Medrano is a board-certified psychiatrist who completed his undergraduate education at Naropa University and the University of Colorado at Denver. He attended medical school at the University of Colorado School of 51����, followed by a residency at Mount Sinai Beth Israel in New York City. His clinical practice is influenced by a lifelong interest in eastern psychology and complementary alternative medicine. These interests are further enhanced by his current fellowship at the Integrative Psychiatry Institute sponsored by the University of Colorado School of 51����.

This webinar was recorded live on December 1st, 2020.

Follow us! ☁️
Official Website:
LinkedIn: https://www.linkedin.com/fieldtriphealth
Facebook: https://www.facebook.com/fieldtriphealth
Twitter: https://www.twitter.com/fieldtriphealth
Instagram: https://www.instagram.com/fieldtriphe...
Listen to our podcast: https://www.fieldtripping.fm
Download our app: https://www.tripapp.co

‍